Gaël Krysa

1.0k total citations
5 papers, 401 citations indexed

About

Gaël Krysa is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Gaël Krysa has authored 5 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 1 paper in Pharmacology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Gaël Krysa's work include TGF-β signaling in diseases (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Gaël Krysa is often cited by papers focused on TGF-β signaling in diseases (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Gaël Krysa collaborates with scholars based in France, United Kingdom and India. Gaël Krysa's co-authors include Françoise Gellibert, Stéphane Huet, Anne‐Charlotte de Gouville, Alain Laroze, Marie-Hélène Fouchet, Jean‐Marie Brusq, Jean‐Michel Gauthier, Ruolan Wang, James M. Woolven and Neil Mathews and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Gaël Krysa

5 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaël Krysa France 4 260 98 59 45 42 5 401
Michelina Coco Italy 12 453 1.7× 63 0.6× 22 0.4× 38 0.8× 21 0.5× 23 593
Elena Navarro‐Villarán Spain 10 224 0.9× 42 0.4× 41 0.7× 56 1.2× 15 0.4× 17 397
Jiunn-Chang Lin Taiwan 11 150 0.6× 152 1.6× 29 0.5× 60 1.3× 8 0.2× 27 426
Leo Tseng United States 9 205 0.8× 178 1.8× 14 0.2× 101 2.2× 23 0.5× 16 487
Frank Schönsiegel Germany 10 211 0.8× 157 1.6× 31 0.5× 21 0.5× 14 0.3× 10 380
Langzhu Tan United States 8 252 1.0× 77 0.8× 20 0.3× 18 0.4× 8 0.2× 9 362
Yen‐Ying Chen Taiwan 9 177 0.7× 63 0.6× 42 0.7× 69 1.5× 26 0.6× 11 317

Countries citing papers authored by Gaël Krysa

Since Specialization
Citations

This map shows the geographic impact of Gaël Krysa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaël Krysa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaël Krysa more than expected).

Fields of papers citing papers by Gaël Krysa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaël Krysa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaël Krysa. The network helps show where Gaël Krysa may publish in the future.

Co-authorship network of co-authors of Gaël Krysa

This figure shows the co-authorship network connecting the top 25 collaborators of Gaël Krysa. A scholar is included among the top collaborators of Gaël Krysa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaël Krysa. Gaël Krysa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Nicodème, Edwige, Florence Blandel, Gaël Krysa, et al.. (2019). Abstract 3228: Immune checkpoint blockade and autoimmune diseases: Development of a mouse model of colitis induced by anti-CTLA-4. Cancer Research. 79(13_Supplement). 3228–3228. 2 indexed citations
2.
Mirguet, Olivier, Yann Lamotte, Chun‐wa Chung, et al.. (2013). Naphthyridines as Novel BET Family Bromodomain Inhibitors. ChemMedChem. 9(3). 580–589. 26 indexed citations
3.
Gellibert, Françoise, et al.. (2009). Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2277–2281. 64 indexed citations
4.
Gouville, Anne‐Charlotte de, Gaël Krysa, Jean‐Marie Brusq, et al.. (2005). Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis. British Journal of Pharmacology. 145(2). 166–177. 143 indexed citations
5.
Gellibert, Françoise, James M. Woolven, Marie-Hélène Fouchet, et al.. (2004). Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors. Journal of Medicinal Chemistry. 47(18). 4494–4506. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelina Coco Breakdown of academic impact, for papers by Elena Navarro‐Villarán Breakdown of academic impact, for papers by Jiunn-Chang Lin Breakdown of academic impact, for papers by Leo Tseng Breakdown of academic impact, for papers by Frank Schönsiegel Breakdown of academic impact, for papers by Langzhu Tan Breakdown of academic impact, for papers by Yen‐Ying Chen
Rankless by CCL
2026